CEFPO CV 50 ORAL SUSPENSION

 

​Cefpo CV contains Cefpodoxime which is third generation cephalosporin, exhibits activity against several Gram positive as well as Gram negative microorganisms and Clavulanic acid which is a natural inhibitor of beta lactamase. It restricts Cefpodoxime destruction. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections. Cefpo CV 50 Oral Suspension is dosage form for pediatric use.

Product Category

ANTI-BIOTICS / ANTI-BACTERIAL

Product Specification

Product Description

​Cefpodoxime 50 mg. & Clavulanic Acid 31.25 mg / 5 ml. Dry Syrup

 

Send Enquiry